Rotavirus Vaccine and the News Media, 1987-2001
CONTEXT In August 1998, the US Food and Drug Administration licensed the first vaccine against rotavirus, the most important cause of severe childhood diarrhea. Fourteen months later, amid intense media activity, the vaccine was withdrawn after an association was found with intussusception. OBJECTIV...
Gespeichert in:
Veröffentlicht in: | JAMA : the journal of the American Medical Association 2002-03, Vol.287 (11), p.1455-1462 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | CONTEXT In August 1998, the US Food and Drug Administration licensed the first
vaccine against rotavirus, the most important cause of severe childhood diarrhea.
Fourteen months later, amid intense media activity, the vaccine was withdrawn
after an association was found with intussusception. OBJECTIVES To examine the character of news media stories about rotavirus vaccine
before and after intussusception became an issue, to evaluate what prompted
the stories, and to assess the extent to which they evoked public reaction. DESIGN AND SETTING We searched Lexis-Nexis and Video Monitoring Services of America databases
for rotavirus vaccine stories from the first US clinical trials (January 1,
1987) until 17 months after withdrawal (March 31, 2001) and examined calls
to the National Immunization Hotline during the period in which rotavirus
vaccine information was captured (July 1–December 31, 1999). MAIN OUTCOME MEASURES Mention of vaccine benefits and adverse events, classification of stories
as positive, negative, or neutral toward the vaccine, story stimuli, and public
response. RESULTS We included 280 newspaper (primary subject of analysis), 49 wire service,
and 257 television stories. Prior to identification of the intussusception
association (January 1, 1987–July 14, 1999), 21% of 188 newspaper stories
mentioned vaccine adverse events and only 2 stories were negative toward the
vaccine. Ninety-nine percent of stories mentioned vaccine benefits. During
the period surrounding withdrawal (July 15–December 31, 1999), 93% of
90 stories mentioned adverse events and 77% were negative toward the vaccine.
Eighty-four percent mentioned vaccine benefits. The rate of stories per month
was 14-fold greater than the preceding period (P |
---|---|
ISSN: | 0098-7484 1538-3598 |
DOI: | 10.1001/jama.287.11.1455 |